Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Supriya Lifescience Ltd. Share Price
Day's Range
Low
₹801.00
High
₹835.00
Price Summary
| Previous Close | ₹818.55 |
|---|---|
| Day's Range | ₹801.00 - ₹835.00 |
| Open | ₹835.00 |
| 52 Week Range | ₹545.50 - ₹1,085.00 |
| Volume | 1,62,923 |
| Market Cap | ₹0.01 |
| Previous Close | ₹818.90 |
|---|---|
| Day's Range | ₹800.90 - ₹835.05 |
| Open | ₹835.05 |
| 52 Week Range | ₹545.65 - ₹1,085.50 |
| Volume | 12,679 |
| Market Cap | ₹0.01 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 1,327.53 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 0.12 |
| Price/Earning (TTM) | 33.22 |
| TTM EPS (₹) | 24.65 |
| P/E Ratio | 21.75 |
| Book Value(₹) | 5.39 |
| PAT Margin (%) | 22.86 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 25.30 |
| Trade Value ( ₹ in Lacs) | 103.08 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 0.12 |
| Price/Earning (TTM) | 33.22 |
| TTM EPS (₹) | 24.65 |
| P/E Ratio | 21.75 |
| Book Value(₹) | 5.39 |
| PAT Margin (%) | 22.86 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 25.30 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 1450.74 | 6964.85 |
| Expenses | N/A | N/A |
| PBT | 474.12 | 2484.81 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 347.9 | 1879.58 |
About Supriya Lifescience Ltd.
| Founded | 2008 |
|---|---|
| Managing Director | Saloni Satish Wagh |
| NSE Symbol | SUPRIYA |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,18,204.09 | 1,743.00 | 1,583.70 - 1,583.70 |
| Divi's Laboratories Ltd. | 2,38,496.97 | 8,984.00 | 5,647.50 - 5,647.50 |
| Torrent Pharmaceuticals Ltd. | 1,70,480.87 | 4,482.00 | 3,532.60 - 3,532.60 |
| Zydus Lifesciences Ltd. | 1,12,503.47 | 1,127.85 | 835.50 - 835.50 |
| Apollo Hospitals Enterprise Ltd. | 1,11,173.58 | 7,731.95 | 6,696.50 - 6,696.50 |
| Lenskart Solutions Ltd. | 1,08,802.30 | 630.00 | 0.00 - 0.00 |
| Cipla Ltd. | 1,08,012.30 | 1,337.00 | 1,165.70 - 1,165.70 |
| Laurus Labs Ltd. | 1,06,657.63 | 1,974.00 | 902.35 - 902.35 |
| Dr. Reddy's Laboratories Ltd. | 1,02,206.60 | 1,224.50 | 1,101.00 - 1,101.00 |
| Mankind Pharma Ltd. | 91,572.10 | 2,217.00 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Supriya Lifescience informs about further update on judicial proceedings
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation to the earlier intimations made by the Company in relation to Judicial Proceedings, Supriya Lifescience has informed that the matter has been admitted by the Hon’ble Supreme Court and is listed for hearing. Further, the Hon’ble Supreme Court has, in the interim, directed that no coercive action shall be taken against the Directors/officers/officials of the petitioner, subject to the terms and conditions of the order passed by the Hon’ble Court. The matter is presently pending before the Hon’ble Court and is sub judice. The Company shall continue to monitor the proceedings and shall keep the Stock Exchanges and its shareholders informed of any material developments in the matter as and when received from the Hon’ble Court or otherwise in accordance with applicable laws and regulations.
Supriya Lifescience informs about ESG ratings
Supriya Lifescience informs about updates
Dr. Reddy's Labs. - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 55726.00 | 46186.00 | 20.66 | 107092.00 | 124281.00 | -13.83 | 205328.00 | 231154.00 | -11.17 |
| Other Income | 2173.00 | 3642.00 | -40.33 | 6577.00 | 7625.00 | -13.74 | 16896.00 | 10034.00 | 68.39 |
| PBIDT | 13120.00 | 8445.00 | 55.36 | 21998.00 | 50798.00 | -56.70 | 56070.00 | 83852.00 | -33.13 |
| Interest | 770.00 | 334.00 | 130.54 | 1501.00 | 526.00 | 185.36 | 1483.00 | 1099.00 | 34.94 |
| PBDT | 12350.00 | 8111.00 | 52.26 | 20497.00 | 50272.00 | -59.23 | 54587.00 | 82753.00 | -34.04 |
| Depreciation | 3337.00 | 2948.00 | 13.20 | 6514.00 | 5746.00 | 13.37 | 12074.00 | 10394.00 | 16.16 |
| PBT | 9013.00 | 5163.00 | 74.57 | 13983.00 | 44526.00 | -68.60 | 42513.00 | 72359.00 | -41.25 |
| TAX | 2055.00 | 1290.00 | 59.30 | 2978.00 | 11041.00 | -73.03 | 10316.00 | 18865.00 | -45.32 |
| Deferred Tax | 86.00 | 513.00 | -83.24 | 508.00 | 847.00 | -40.02 | 1139.00 | 960.00 | 18.65 |
| PAT | 6958.00 | 3873.00 | 79.65 | 11005.00 | 33485.00 | -67.13 | 32197.00 | 53494.00 | -39.81 |
| Equity | 835.00 | 835.00 | 0.00 | 835.00 | 835.00 | 0.00 | 835.00 | 834.00 | 0.12 |
| PBIDTM(%) | 23.54 | 18.28 | 28.76 | 20.54 | 40.87 | -49.74 | 27.31 | 36.28 | -24.72 |
Torrent Pharma - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 41450.00 | 27620.00 | 50.07 | 83030.00 | 53780.00 | 54.39 | 107120.00 | 96820.00 | 10.64 |
| Other Income | -110.00 | -270.00 | -59.26 | -320.00 | -320.00 | 0.00 | 180.00 | 320.00 | -43.75 |
| PBIDT | 15600.00 | 10450.00 | 49.28 | 31120.00 | 20190.00 | 54.14 | 40720.00 | 36070.00 | 12.89 |
| Interest | 2870.00 | 370.00 | 675.68 | 5800.00 | 820.00 | 607.32 | 3410.00 | 2130.00 | 60.09 |
| PBDT | 12630.00 | 9950.00 | 26.93 | 25010.00 | 19240.00 | 29.99 | 36610.00 | 33700.00 | 8.64 |
| Depreciation | 5870.00 | 1890.00 | 210.58 | 11620.00 | 3760.00 | 209.04 | 7640.00 | 7600.00 | 0.53 |
| PBT | 6760.00 | 8060.00 | -16.13 | 13390.00 | 15480.00 | -13.50 | 28970.00 | 26100.00 | 11.00 |
| TAX | 1780.00 | 2090.00 | -14.83 | 3490.00 | 4000.00 | -12.75 | 7050.00 | 7220.00 | -2.35 |
| Deferred Tax | -820.00 | -110.00 | 645.45 | -1770.00 | -180.00 | 883.33 | -150.00 | 1810.00 | -108.29 |
| PAT | 4980.00 | 5970.00 | -16.58 | 9900.00 | 11480.00 | -13.76 | 21920.00 | 18880.00 | 16.10 |
| Equity | 1901.80 | 1692.30 | 12.38 | 1901.80 | 1692.30 | 12.38 | 1692.30 | 1692.30 | 0.00 |
| PBIDTM(%) | 37.64 | 37.83 | -0.53 | 37.48 | 37.54 | -0.16 | 38.01 | 37.25 | 2.04 |
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Supriya Lifescience Ltd. is ₹818.55 as of 2026-10-23.
The market capitalisation of Supriya Lifescience Ltd. is ₹6,590.74 as of 2026-10-23.
The 1-year return of Supriya Lifescience Ltd. is 74.10% as of 2026-10-23.
The P/E ratio of Supriya Lifescience Ltd. is 21.75 as of 2026-10-24.
The 52-week high and low of Supriya Lifescience Ltd. are ₹1,085.00 and ₹545.50, respectively, as of 2026-10-23.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
